(Funded by the U.S. National Science Foundation and the National Institutes of Health)
Researchers from Georgia Tech and the University of California Riverside have developed biosensors made of iron oxide nanoparticles and special molecules called cyclic peptides that recognize tumor cells better than current biosensors. The cyclic peptides respond only when they encounter two specific types of enzymes – one secreted by the immune system, the other by cancer cells. In animal studies, the biosensors distinguished between tumors that responded to a common cancer treatment that enhances the immune system from tumors that resisted treatment.

(Funded by the U.S. Department of Energy and the U.S. Department of Defense)
Researchers from Columbia University, the University of Chicago, the University of Vienna in Austria, Politecnico di Milano in Italy, and Universita Degli Studi Dell’ Aquila in Italy have created a device that can generate photon pairs more efficiently than previous methods while being less prone to error. To create the device, the researchers used thin crystals of a van der Waals semiconducting transition metal called molybdenum disulfide. Then, they layered six of these crystal pieces into a stack, with each piece rotated 180 degrees relative to the crystal slabs above and below. As light travels through this stack, a phenomenon called quasi-phase-matching manipulates properties of the light, enabling the creation of paired photons. “We believe this breakthrough will establish van der Waals materials as the core of next-generation nonlinear and quantum photonic architectures,” said James Schuck, one of the scientists involved in this study.

(Funded by the National Institutes of Health)
Most cancers occur when there is an imbalance of cellular growth and inhibition, causing cells to grow rapidly and form tumors in the body. In the case of prostate cancer, no therapies exist to simultaneously correct tumor growth and restore tumor suppression. To restore this balance, researchers from Brigham and Women’s Hospital, which is part of Harvard Medical School, have used lipid nanoparticles to deliver messenger RNA (mRNA) and small interfering RNA (siRNA) to human prostate cancer cells. This approach was successful in preclinical models, holding promise for suppressing tumor growth in patients.

(Funded by the U.S. Department of Energy)
Researchers from the U.S. Department of Energy’s Argonne National Laboratory and the University of Cambridge have unveiled the existence of an intriguing link between ferroelectric domain walls and electron interactions in a type of van der Waals 2D material. A domain wall is a boundary or interface separating regions inside a material that exhibit different orientations of ferroelectric polarization. The link discovered by the researchers gives rise to a new type of superconductivity that is unique to these 2D materials. “We showed that places like domain walls, typically associated with irregularities and potentially harmful for things like superconductivity, can indeed be helpful for superconductivity,” said Gaurav Chaudhary and Ivar Martin, the two authors of this study.

(Funded by the U.S. Department of Energy)
Researchers from the U.S. Department of Energy’s SLAC National Accelerator Laboratory, Stanford University, and the University of California, Davis, have developed a new software tool that can provide more quantitative details about the structure of the active sites in single atom catalysts in much less time, compared to current methods. Normally, a catalyst uses an inert support to stabilize nanometer-sized clusters of metal atoms, or metal nanoparticles. To maximize the use of each metal atom, researchers also use single atom catalysts, where individual metal atoms are dispersed onto the support. In reality, catalysts usually have both single atoms and nanoparticles, and the new software tool determines the fractions of these two forms.